PL364638A1 - Związki karbaminianowe do stosowania w zapobieganiu lub leczeniu zaburzeń dwubiegunowych - Google Patents

Związki karbaminianowe do stosowania w zapobieganiu lub leczeniu zaburzeń dwubiegunowych

Info

Publication number
PL364638A1
PL364638A1 PL02364638A PL36463802A PL364638A1 PL 364638 A1 PL364638 A1 PL 364638A1 PL 02364638 A PL02364638 A PL 02364638A PL 36463802 A PL36463802 A PL 36463802A PL 364638 A1 PL364638 A1 PL 364638A1
Authority
PL
Poland
Prior art keywords
preventing
bipolar disorder
phenyl
alkyl
treating bipolar
Prior art date
Application number
PL02364638A
Other languages
English (en)
Inventor
Carlos R. Plata-Salaman
Boyu Zhao
Roy E. Twyman
Yong Moon Choi
Robert Gordon
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of PL364638A1 publication Critical patent/PL364638A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
PL02364638A 2001-02-27 2002-02-21 Związki karbaminianowe do stosowania w zapobieganiu lub leczeniu zaburzeń dwubiegunowych PL364638A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
PL364638A1 true PL364638A1 (pl) 2004-12-13

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364638A PL364638A1 (pl) 2001-02-27 2002-02-21 Związki karbaminianowe do stosowania w zapobieganiu lub leczeniu zaburzeń dwubiegunowych

Country Status (26)

Country Link
US (1) US6562867B2 (pl)
EP (1) EP1408953B1 (pl)
JP (1) JP4276837B2 (pl)
KR (1) KR100946944B1 (pl)
CN (1) CN1250215C (pl)
AT (1) ATE324108T1 (pl)
BR (1) BR0207644A (pl)
CA (1) CA2439475C (pl)
CY (1) CY1105330T1 (pl)
CZ (1) CZ20032300A3 (pl)
DE (1) DE60210976T2 (pl)
DK (1) DK1408953T3 (pl)
ES (1) ES2262801T3 (pl)
HU (1) HUP0303243A3 (pl)
IL (1) IL157590A0 (pl)
MX (1) MXPA03007717A (pl)
MY (1) MY129304A (pl)
NO (1) NO20033802L (pl)
NZ (1) NZ527988A (pl)
PL (1) PL364638A1 (pl)
PT (1) PT1408953E (pl)
RS (1) RS50677B (pl)
RU (1) RU2300372C2 (pl)
TW (1) TWI250872B (pl)
WO (1) WO2002067921A1 (pl)
ZA (1) ZA200307465B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE267629T1 (de) * 2000-07-21 2004-06-15 Ortho Mcneil Pharm Inc Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen
EP1383489B1 (en) * 2001-02-27 2007-05-09 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
IL157594A0 (en) 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating anxiety disorders
ATE435014T1 (de) 2001-07-16 2009-07-15 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
DK1809273T3 (da) * 2004-09-16 2010-08-02 Janssen Pharmaceutica Nv Anvendelse af 2-phenyl-1,2-ethandiol-(di)carbamater til behandling af epileptogenese
EP1890684B1 (en) 2005-06-08 2013-08-14 SK Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
BRPI0718323A2 (pt) * 2006-10-31 2013-11-26 Janssen Pharmaceutica Nv Tratamento de transtornos invasivos do desenvolvimento.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN105189451A (zh) * 2013-03-12 2015-12-23 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
MX2019006940A (es) * 2016-12-14 2019-09-06 Sk Biopharmaceuticals Co Ltd Uso de compuestos de carbamato para prevencion, alivio o tratamiento del trastorno bipolar.
BR112019025286A2 (pt) 2017-06-02 2020-06-23 Jazz Pharmaceuticals Ireland Limited Métodos e composições para tratamento de sonolência excessiva
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
WO1995034563A1 (en) * 1994-06-16 1995-12-21 Pfizer Inc. Pyrazolo and pyrrolopyridines
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
JP4276837B2 (ja) 2009-06-10
ES2262801T3 (es) 2006-12-01
WO2002067921A1 (en) 2002-09-06
CY1105330T1 (el) 2010-03-03
DK1408953T3 (da) 2006-08-21
HK1063436A1 (en) 2004-12-31
BR0207644A (pt) 2004-03-09
RU2300372C2 (ru) 2007-06-10
EP1408953A1 (en) 2004-04-21
DE60210976D1 (de) 2006-06-01
CN1505506A (zh) 2004-06-16
KR20030087010A (ko) 2003-11-12
NO20033802D0 (no) 2003-08-26
RU2003128997A (ru) 2005-03-20
ATE324108T1 (de) 2006-05-15
PT1408953E (pt) 2006-07-31
TWI250872B (en) 2006-03-11
NO20033802L (no) 2003-10-22
HUP0303243A2 (hu) 2004-01-28
CA2439475A1 (en) 2002-09-06
RS50677B (sr) 2010-06-30
YU67803A (sh) 2006-08-17
MY129304A (en) 2007-03-30
DE60210976T2 (de) 2007-05-24
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
KR100946944B1 (ko) 2010-03-15
CA2439475C (en) 2010-05-18
ZA200307465B (en) 2005-03-17
IL157590A0 (en) 2004-03-28
CZ20032300A3 (cs) 2005-01-12
EP1408953B1 (en) 2006-04-26
US20020198257A1 (en) 2002-12-26
HUP0303243A3 (en) 2012-07-30
CN1250215C (zh) 2006-04-12
JP2004533415A (ja) 2004-11-04
US6562867B2 (en) 2003-05-13

Similar Documents

Publication Publication Date Title
NO20071921L (no) Fremgangsmater for behandling av epileptogenese og epilepsi
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
IL157590A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
YU68003A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
IL157594A0 (en) Carbamate compounds for use in preventing or treating anxiety disorders
IL154052A0 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
IL159847A0 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
PL368112A1 (pl) Związki karbaminianowe do stosowania w zapobieganiu lub leczeniu bólu neuropatycznego i bólu związanego z bólem głowy i migreną
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
TW200701978A (en) Methods of treating epileptogenesis and epilepsy

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)